Bottom line
GTHRX vs HIAHX: the short answer
GTHRX (INVESCO Health Care Fund) and HIAHX (Hartford Healthcare Hls Fund) are both mutual funds.
HIAHX is cheaper at 0.94% vs 1.32% — a difference of $38 a year per $10,000 invested.
Over five years, GTHRX returned +3.5% a year vs +3.5% for HIAHX.
Updated Nov 19, 2026
GTHRX vs HIAHX side by side
| GTHRX | HIAHX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Invesco | Hartford |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.32% | 0.94% |
| Annual cost per $10k | $132 | $94 |
| 10-yr cost on $10k (prospectus) | $1,590 | $1,155 |
| Max front load | 0% | — |
| 12b-1 fee | 0.5% | 0% |
| 1-yr return | +15.2% | +16.1% |
| 5-yr return (annualized) | +3.5% | +3.5% |
| 10-yr return (annualized) | +6.1% | +7.9% |
| Best quarter | +19.6% | +21.0% |
| Worst quarter | −16.5% | −15.6% |
| Net assets (fund) | $1.2B | $112.4M |
| Number of holdings | 82 | 79 |
| Portfolio turnover | 59% | 5% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | GTHRX | HIAHX | Difference |
|---|---|---|---|
| 2024 | +4.0% | +0.4% | +3.6% |
| 2023 | +3.1% | +4.1% | −1.1% |
| 2022 | −13.5% | −11.2% | −2.3% |
| 2021 | +12.2% | +10.0% | +2.2% |
| 2020 | +14.5% | +23.1% | −8.7% |
| 2019 | +32.0% | +34.0% | −2.0% |
| 2018 | +0.5% | −2.7% | +3.1% |
| 2017 | +15.5% | +22.3% | −6.8% |
| 2016 | −11.7% | −8.4% | −3.3% |
Source: Fund prospectus bar charts
Holdings overlap
10 of GTHRX's top 25 holdings also appear in HIAHX's top 25.
| Holding | GTHRX | HIAHX |
|---|---|---|
| Eli Lilly and Co. | 10.59% | 12.47% |
| Johnson & Johnson | 6.76% | 6.63% |
| UnitedHealth Group Inc. | 6.17% | 4.72% |
| Merck & Co., Inc. | 4.59% | 6.60% |
| AbbVie Inc. | 4.03% | 3.43% |
| CVS Health Corp. | 2.52% | 2.93% |
| Cardinal Health, Inc. | 2.10% | 1.81% |
| Vertex Pharmaceuticals Inc. | 2.01% | 2.69% |
| Edwards Lifesciences Corp. | 1.56% | 2.42% |
| Thermo Fisher Scientific Inc. | 1.55% | 1.64% |
Source: SEC Form N-PORT
GTHRX top 10
- Eli Lilly and Co. — 10.59%
- Johnson & Johnson — 6.76%
- UnitedHealth Group Inc. — 6.17%
- Invesco Private Prime Fund — 4.67%
- Merck & Co., Inc. — 4.59%
- AbbVie Inc. — 4.03%
- Gilead Sciences, Inc. — 3.63%
- argenx SE — 3.24%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
HIAHX top 10
- Eli Lilly & Co — 12.47%
- Johnson & Johnson — 6.63%
- Merck & Co Inc — 6.60%
- UnitedHealth Group Inc — 4.72%
- AbbVie Inc — 3.43%
- Intuitive Surgical Inc — 2.99%
- Elevance Health Inc — 2.96%
- CVS Health Corp — 2.93%
- Vertex Pharmaceuticals Inc — 2.69%
- Danaher Corp — 2.65%
FAQ
What is the difference between GTHRX and HIAHX?
Which is cheaper, GTHRX or HIAHX?
Should I own both GTHRX and HIAHX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.